http://purl.org/np/RAqc_p-BPO... RAqc_p-BPO

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom

https://dailymed.nlm.nih.gov/d...c4-2a40-485c-b7cb-96a9b85d9d11 drugInfo.cfm?setid=0ce2c1c4-2a40-485c-b7cb-96a9b85d9d11

Leoni Bücken

2021-04-03T10:23:25.387Z

http://purl.org/np/RAqc_p-BPO... RAqc_p-BPO

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/ns/prov#value value

RADICAVA is indicated for the treatment of amyotrophic lateral sclerosis (ALS).

Leoni Bücken

2021-04-03T10:23:25.387Z

http://purl.org/np/RAqc_p-BPO... RAqc_p-BPO

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://purl.org/np/RAqc_p-BPO...#medtherapy medtherapy

http://www.w3.org/ns/prov#wasDerivedFrom wasDerivedFrom

Leoni Bücken

2021-04-03T10:23:25.387Z